ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 91 filers reported holding ADURO BIOTECH INC in Q3 2017. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $45,000 | +221.4% | 3,080 | -42.1% | 0.00% | – |
Q2 2020 | $14,000 | +40.0% | 5,318 | -38.1% | 0.00% | – |
Q4 2019 | $10,000 | +66.7% | 8,598 | +49.6% | 0.00% | – |
Q3 2019 | $6,000 | -33.3% | 5,747 | +3.6% | 0.00% | – |
Q2 2019 | $9,000 | +50.0% | 5,547 | +256.3% | 0.00% | – |
Q1 2019 | $6,000 | +200.0% | 1,557 | +72.4% | 0.00% | – |
Q4 2018 | $2,000 | -33.3% | 903 | +103.8% | 0.00% | – |
Q3 2018 | $3,000 | -50.0% | 443 | -53.5% | 0.00% | – |
Q2 2018 | $6,000 | +20.0% | 952 | +91.9% | 0.00% | – |
Q1 2018 | $5,000 | +25.0% | 496 | -6.6% | 0.00% | – |
Q4 2017 | $4,000 | -60.0% | 531 | -40.9% | 0.00% | – |
Q3 2017 | $10,000 | -23.1% | 899 | -22.2% | 0.00% | – |
Q2 2017 | $13,000 | +62.5% | 1,156 | +50.5% | 0.00% | – |
Q1 2017 | $8,000 | -46.7% | 768 | -39.7% | 0.00% | – |
Q4 2016 | $15,000 | -11.8% | 1,274 | -7.0% | 0.00% | – |
Q3 2016 | $17,000 | +112.5% | 1,370 | +101.2% | 0.00% | – |
Q2 2016 | $8,000 | -92.8% | 681 | -92.2% | 0.00% | – |
Q1 2016 | $111,000 | – | 8,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 2,106,734 | $40,807,000 | 12.39% |
Rock Springs Capital Management LP | 415,000 | $8,039,000 | 0.65% |
CLOUGH CAPITAL PARTNERS L P | 592,697 | $11,481,000 | 0.50% |
NJ State Employees Deferred Compensation Plan | 53,300 | $1,032,000 | 0.22% |
Orbimed Advisors | 1,065,522 | $20,639,000 | 0.21% |
Point72 Asset Management, L.P. | 845,700 | $16,381,000 | 0.13% |
LMCG INVESTMENTS, LLC | 244,382 | $4,734,000 | 0.10% |
EverPoint Asset Management, LLC | 150,000 | $2,906,000 | 0.08% |
M&T BANK CORP | 566,560 | $10,974,000 | 0.08% |
GLOBEFLEX CAPITAL L P | 15,200 | $294,000 | 0.06% |